Most Read News

Here are some of the stocks that may see significant price movement today: BHEL, IRCTC, Birlasoft, Bajaj Healthcare, etc.

The company’s operating EBITDA stood at ₹127 Crore, up by 5.30% y-o-y, over ₹120.60 Crore in the previous corresponding period.

The company reported a 13.70% year-on-year growth in its net profit at ₹341 Crore, against ₹300 Crore in the previous comparable quarter.

With a revenue potential of ₹350-400 crore, the project would be launched in the early part of FY26.

Top losers in Sensex include Zomato (-5.17%), Power Grid Corp (-3.05%), Tata Motors (-2.62%), Adani ports (-2.24%), and Titan Company (-2.72%).

The company’s operating EBITDA, witnessed about 9 fold growth to ₹852.20 Crore compared to ₹97.30 Crore.

The stock has gained a total of 28% in the last one year, and 0.79% gain in the last one month.

Ipratropium Bromide Nasal Solution (0.03%) is indicated for the symptomatic relief of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis.

Revenue grew by 39% YoY, reaching ₹458.3 crore, compared to ₹330 crore in the same period last year.

The company’s EBITDA surged 78.50% to ₹158.10 Crore in the quarter under review, as compared to ₹88.60 Crore in Q3FY24.